Adjuvant multipeptide vaccination in high-risk renal cell carcinoma

被引：0
|
作者：
Feyerabend, S.
Gouttefangeas, C.
Stevanovic, S.
Wernet, D., Sr.
Hennenlotter, J.
Bedke, J.
Droege, A.
Laske, K.
Rammensee, H.
Stenzl, A.
机构：
[1] Urol Univ Clin, Tubingen, Germany
[2] Univ Tubingen, Dept Zellbiol, Tubingen, Germany
[3] Univ Tubingen, Inst Cell Biol, Dept Immunol, Tubingen, Germany
[4] Univ Tubingen, Inst Transfus Med, Tubingen, Germany
[5] Univ Tubingen, Urol Clin, Tubingen, Germany
[6] Univ Tubingen, Tubingen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e15051
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15051
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adjuvant multipeptide vaccination in high-risk early melanoma patients
    Filipazzi, P.
    Pilla, L.
    Patuzzo, R.
    Castelli, C.
    Maurichi, A.
    Tragni, G.
    Maio, M.
    Parmiani, G.
    Santinami, M.
    Rivoltini, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Adjuvant and Neoadjuvant Therapies in High-Risk Renal Cell Carcinoma
    Smaldone, Marc C.
    Fung, Chunkit
    Uzzo, Robert G.
    Haas, Naomi B.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (04) : 765 - +
  • [3] Adjuvant therapy for high-risk renal cell carcinoma patients
    Kunkle D.A.
    Haas N.B.
    Uzzo R.G.
    Current Urology Reports, 2007, 8 (1) : 19 - 30
  • [4] Adjuvant Therapy for Localized High-Risk Renal Cell Carcinoma
    Wood, Erika
    Donin, Nicholas
    Shuch, Brian
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (03) : 345 - +
  • [5] Adjuvant Treatment of High-risk Renal Cell Carcinoma: Leaving the Desert?
    Kroeger, Nils
    Stenzl, Arnulf
    Burchardt, Martin
    Bedke, Jens
    EUROPEAN UROLOGY, 2017, 71 (05) : 695 - 696
  • [6] The current status of adjuvant treatment for high-risk renal cell carcinoma
    Hizal, Mutlu
    Sendur, Mehmet A. N.
    Bilgin, Burak
    Akinci, Muhammed Bulent
    Dede, Didem Sener
    Yalcin, Bulent
    FUTURE ONCOLOGY, 2017, 13 (23) : 2017 - 2020
  • [7] Are We Ready for Adjuvant Sunitinib in High-risk Renal Cell Carcinoma?
    Casuscelli, Jozefina
    Hsieh, James J.
    EUROPEAN UROLOGY, 2018, 73 (01) : 69 - 70
  • [8] Role of adjuvant systemic therapy in high-risk renal cell carcinoma
    Aydogdu, C.
    Casuscelli, J.
    ONKOLOGIE, 2023, 29 (07): : 622 - 631
  • [9] Adjuvant treatment of high-risk renal cell carcinoma: the jury is still out
    Procopio, G.
    Sepe, P.
    Verzoni, E.
    Pignata, S.
    Bamias, A.
    ANNALS OF ONCOLOGY, 2018, 29 (10) : 2030 - 2032
  • [10] Adjuvant immunotherapy for high-risk renal cell carcinoma-now or never?
    Kulasegaran, Tivya
    Oliveira, Niara
    Gedye, Craig
    Sengupta, Shomik
    BJU INTERNATIONAL, 2025, 135 (02) : 235 - 236
12345